NCT04295161View on ClinicalTrials.gov

A Study Designed to Evaluate the Pharmacokinetic Profile of Abiraterone

PHASE1CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

June 25, 2019

Primary Completion Date

November 8, 2019

Study Completion Date

November 8, 2019

Conditions
Pharmacokinetics
Interventions
DRUG

Abiraterone Acetate

Abiraterone acetate immediate release formulations

Trial Locations (1)

Unknown

Quotient Sciences, Ruddington

All Listed Sponsors
lead

Zentiva, k.s.

INDUSTRY

NCT04295161 - A Study Designed to Evaluate the Pharmacokinetic Profile of Abiraterone | Biotech Hunter | Biotech Hunter